Nikoglou, E: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis from the Perspective of the Scottish National Health Service (NHS)

E. Nikoglou, S. Humphreys, A. El khoury, S.A. Ferrante, C. O' Regan

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 60 KB

english, 2011

2

PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in Scotland

Nikoglou, E., Humphreys, S., Pellissier, J., O' Regan, C.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 61 KB

english, 2011

3

Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection

Gervais, F., Jiang, Y., Largeron, N., Nikoglou, T.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 60 KB

english, 2014

4

Estimating The Public Health Impact Of A Vaccination Programme With A Nonavalent Hpv Vaccine In Germany

Largeron, N, Petry, K, Jacob, JA, Bianic, F, Anger, D, Nikoglou, T

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 70 KB

english, 2015

5

Estimating The Cost-Effectiveness Profile of A Universal Vaccination Programme With A Nine-Valent Hpv Vaccine In Austria

Boiron, L, Joura, E, Largeron, N, Prager, B, Nikoglou, T

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 52 KB

english, 2015

6

Budget Impact of Secukinumab For Ankylosing Spondylitis In The UK

Halliday, A, Hacking, V, Jugl, SM, Gunda, P, Nikoglou, E, Miles, L, Graham, CN

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 66 KB

english, 2016

7

A Cost Per Responder Analysis of Secukinumab Vs Adalimumab Based on A Matching-Adjusted Indirect Comparison For The Treatment of Ankylosing Spondylitis From A German Payer Perspective

Gunda, P, Kandhare, A, Nikoglou, E, Jugl, SM, Kneidl, J, Neidhardt, K

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 63 KB

english, 2016

8

Secukinumab Vs Adalimumab for the Treatment of Ankylosing Spondilytis: A Cost Per Responder Analysis at 52 Weeks from a Moroccan Perspective

Kooli, A, Gunda, P, Toumi, J, Nikoglou, E, Jugl, SM

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 60 KB

english, 2017

9

Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective

Chiva-Razavi, S, Jain, M, Graham, CN, Miles, L, Nikoglou, E, Gunda, P

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 83 KB

english, 2017

10

A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatmetn of Psoriatic Arthritis at 48 Weeks from the Irish Payer Perspective

Gunda, P, Nikoglou, E, Jugl, SM, Murphy, A

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 76 KB

english, 2017

11

Secukinumab Vs. Adalimumab for Treatment of Ankylosing Spondylitis: A Cost Per Responder Analysis at 52 Weeks from an Argentinian Perspective

Barbeau, M, Bianculli, PM, Nikoglou, E, Gunda, P, Jugl, SM, MacPherson, A

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 58 KB

english, 2017

12

Assessment of RELAP5/MOD3.3 against single rod reflooding experiments

Lymperea, Niki, Nikoglou, Andreas, Hinis, Evangelos

Journal:

ASCE-ASME J. Risk and Uncert. in Engrg. Sys., Part B: Mech. Engrg.

Year:

2017

Language:

english

File:

PDF, 1.24 MB

english, 2017

13

Comparison of Secukinumab Vs Infliximab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

Kooli, A, Gunda, P, Toumi, J, Nikoglou, E, Jugl, SM

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 62 KB

english, 2017

14

A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Ankylosing Spondylitis at 52 Weeks from the Irish Payer Perspective

Gunda, P, Nikoglou, E, Jugl, SM, Murphy, A

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 58 KB

english, 2017

15

Comparison Ofsecukinumab Vs Adalimumab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

Kooli, A, Gunda, P, Toumi, J, Nikoglou, E, Jugl, SM

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 61 KB

english, 2017

16

Secukinumab Vs. Adalimumab for the Treatment of Psoriatic Arthritis: A Cost Per Responder Analysis at 48 Weeks from an Argentinian Perspective

Barbeau, M, Bianculli, PM, Nikoglou, E, Gunda, P, Jugl, SM, MacPherson, A

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 82 KB

english, 2017

17

E69. BUDGET IMPACT OF SECUKINUMAB FOR ANKYLOSING SPONDYLITIS IN THE UNITED KINGDOM

Halliday, Anna, Hacking, Victoria, Jugl, Steffen, Gunda, Praveen, Nikoglou, Efthalia, Miles, LaStella, Graham, Christopher N.

Journal:

Year:

2017

Language:

english

File:

PDF, 44 KB

english, 2017

18

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation

Kaloyannidis, Panayotis, Hertzberg, Mark, Webb, Kate, Zomas, Athanasios, Schrover, Rudolf, Hurst, Michael, Jacob, Ian, Nikoglou, Thalia, Connors, Joseph M.

Journal:

British Journal of Haematology

Year:

2019

Language:

english

File:

PDF, 247 KB

english, 2019

19

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation

Kaloyannidis, Panayotis, Hertzberg, Mark, Webb, Kate, Zomas, Athanasios, Schrover, Rudolf, Hurst, Michael, Jacob, Ian, Nikoglou, Thalia, Connors, Joseph M.

Journal:

British Journal of Haematology

Year:

2019

File:

PDF, 247 KB

2019

20

[IEEE 2019 4th South-East Europe Design Automation, Computer Engineering, Computer Networks and Social Media Conference (SEEDA-CECNSM) - Piraeus, Greece (2019.9.20-2019.9.22)] 2019 4th South-East Europe Design Automation, Computer Engineering, Computer Networks and Social Media Conference (SEEDA-CECNSM) - A Hybrid Method for Sentiment Analysis of Election Related Tweets

Beleveslis, Dimosthenis, Tjortjis, Christos, Psaradelis, Dimitris, Nikoglou, Dimitris

Year:

2019

File:

PDF, 600 KB

2019

21

Long-Term Survival of Patients with Advanced Melanoma Treated Second Line with Ipilimumab

Lee, D., Pericleous, L., Lebmeier, M., Winn, B., Batty, A., Nikoglou, T.

Journal:

Annals of Oncology

Year:

2012

File:

PDF, 59 KB

2012